Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jörg Hülsken is active.

Publication


Featured researches published by Jörg Hülsken.


Developmental Biology | 2003

β-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system

Dietmar Zechner; Yasuyuki Fujita; Jörg Hülsken; Thomas Müller; Ingrid Walther; Makoto M. Taketo; E. Bryan Crenshaw; Walter Birchmeier; Carmen Birchmeier

beta-Catenin is an essential component of the canonical Wnt signaling system that controls decisive steps in development. We employed here two conditional beta-catenin mutant alleles to alter beta-catenin signaling in the central nervous system of mice: one allele to ablate beta-catenin and the second allele to express a constitutively active beta-catenin. The tissue mass of the spinal cord and brain is reduced after ablation of beta-catenin, and the neuronal precursor population is not maintained. In contrast, the spinal cord and brain of mice that express activated beta-catenin is much enlarged in mass, and the neuronal precursor population is increased in size. beta-Catenin signals are thus essential for the maintenance of proliferation of neuronal progenitors, controlling the size of the progenitor pool, and impinging on the decision of neuronal progenitors to proliferate or to differentiate.


Current Opinion in Cell Biology | 1994

TUMOR-SUPPRESSOR GENE PRODUCTS IN CELL CONTACTS : THE CADHERIN-APC-ARMADILLO CONNECTION

Jörg Hülsken; Jürgen Behrens; Walter Birchmeier

Various structural components of intercellular junctions have recently been found to represent (or be related to) products of tumor-suppressor genes. The tumor-suppressor gene product adenomatous polyposis coli (APC) binds to beta 2-catenin (homologous to the product of Drosophila armadillo), which is cytoplasmically associated with the cell adhesion molecule E-cadherin.


Current Topics in Microbiology and Immunology | 1996

Epithelial Differentiation and the Control of Metastasis in Carcinomas

Walter Birchmeier; Jürgen Behrens; K M Weidner; Jörg Hülsken; Carmen Birchmeier

Tumors of epithelial origin (carcinomas) are of major medical importance (DeVita et al. 1993). Multiple genetic changes in dominant and recessive oncogenes that contribute to carcinoma formation and progression have been identified. The most frequent mutations found in carcinomas include activating mutations in the ras family of genes, mutations that interfere with the function of p53, and amplification or overexpression of genes encoding tyrosine kinase receptors (Barbacid 1987; Aronson 1991; Hollstein et al. 1991; Vogelstein and Kinzler 1993; Hinds and Weinberg 1994). These mutations affect both the growth and the genetic stability of affected cells. A further critical step in the development of malignant carcinomas is their ability to invade the underlying tissue and to metastasize to distant sites. Early genetic approaches for the analysis of oncogenes have focused mainly on the induction of transformation, i.e., unregulated growth in fibroblasts, which has led in the past decade to a wealth of data on the pathways controlling normal and aberrant growth. In comparison, there has been a lag in understanding the molecular causes leading to the acquisition of the metastatic potential of carcinoma cells.


Cancer Letters | 1997

Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines

Claudia Denk; Jörg Hülsken; Elisabeth Schwarz

Cell-cell adhesion mediated by E-cadherin is often lost or disturbed in human carcinomas. For regular adhesive function, E-cadherin has to form complexes with peripheral cytoplasmic catenins which are multifunctional proteins that are also involved in signal transduction and growth regulation. We have analyzed the expression levels of the genes encoding alpha-catenin, beta-catenin and plakoglobin in correlation to the E-cadherin expression levels in cell lines derived from human cervical carcinomas. Reduced mRNA and protein levels were detected for plakoglobin, whereas alpha- and beta-catenin showed only reduced protein (but not mRNA) levels. The alterations in catenin gene expression were often associated with absent or reduced E-cadherin. The findings indicate that a reduction of catenin gene expression may contribute to the development of cervical carcinomas.


Journal of Cell Biology | 1994

E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.

Jörg Hülsken; Walter Birchmeier; Jürgen Behrens


Development | 2002

Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours

Catherin Niemann; David M. Owens; Jörg Hülsken; Walter Birchmeier; Fiona M. Watt


Journal of Cell Biology | 2000

Essential Role of Gab1 for Signaling by the C-Met Receptor in Vivo

Martin M. Sachs; Henning Brohmann; Dietmar Zechner; Thomas Müller; Jörg Hülsken; Ingrid Walther; Ute Schaeper; Carmen Birchmeier; Walter Birchmeier


Genomics | 1994

Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development

Cornelia Kraus; Thomas Liehr; Jörg Hülsken; Jürgen Behrens; Walter Birchmeier; Karl-Heinz Grzeschik; Wolfgang G. Ballhausen


Cancer surveys | 1995

Adherens junction proteins in tumour progression.

Walter Birchmeier; Jörg Hülsken; Jürgen Behrens


Ciba Foundation Symposium 189 - Cell Adhesion and Human Disease | 2007

E‐Cadherin as an Invasion Suppressor

Walter Birchmeier; Jörg Hülsken; Jürgen Behrens

Collaboration


Dive into the Jörg Hülsken's collaboration.

Top Co-Authors

Avatar

Walter Birchmeier

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar

Jürgen Behrens

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors

Avatar

Carmen Birchmeier

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar

Dietmar Zechner

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar

Ingrid Walther

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar

Thomas Müller

Max Delbrück Center for Molecular Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Claudia Denk

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Cornelia Kraus

University of Erlangen-Nuremberg

View shared research outputs
Researchain Logo
Decentralizing Knowledge